A case of a middle-aged patient with a ventricular septal defect complicated by severe pulmonary hypertension-stepwise surgical repair with pulmonary vasodilators.

Pulmonary arterial hypertension Treat-and-repair strategy Ventricular septal defect

Journal

Journal of cardiology cases
ISSN: 1878-5409
Titre abrégé: J Cardiol Cases
Pays: Japan
ID NLM: 101549579

Informations de publication

Date de publication:
Sep 2021
Historique:
received: 18 11 2020
revised: 17 02 2021
accepted: 20 02 2021
entrez: 1 9 2021
pubmed: 2 9 2021
medline: 2 9 2021
Statut: epublish

Résumé

We report a case of ventricular septal defect (VSD) in which we attempted to treat pulmonary arterial hypertension (PAH) with the goal of VSD closure in an adult with suspected Eisenmenger syndrome in childhood. Four years previously (age 41 years), she was referred to our department due to repeated hemoptysis requiring further treatment of PAH. We started combination therapy with several pulmonary vasodilators. Two years later, her pulmonary vascular resistance (PVR) was improved but still not at the level where VSD closure was possible. To control the increased PA flow resulting from intensive PAH treatment and to reduce the risk of hemoptysis, we performed pulmonary artery banding (PAB). As the risk of hemoptysis decreased, a prostacyclin analog was introduced, and the dose was increased. More than 1 year after PAB, active vasoactivity testing became positive, suggesting that the pulmonary vascular lesion was now "reversible". We performed VSD closure and atrial septal defect creation even though her PVR was still high. After the operation, her exercise capacity was remarkably improved. We suggest that stepwise surgical repair with pulmonary vasodilators is an important treatment option for select patients with VSD with severe PAH. <

Identifiants

pubmed: 34466177
doi: 10.1016/j.jccase.2021.02.013
pii: S1878-5409(21)00026-8
pmc: PMC8380949
doi:

Types de publication

Case Reports

Langues

eng

Pagination

131-135

Informations de copyright

© 2021 Japanese College of Cardiology. Published by Elsevier Ltd.

Déclaration de conflit d'intérêts

The authors declare that there is no conflict of interest.

Références

Circ Heart Fail. 2017 Sep;10(9):
pubmed: 28912263
Eur Heart J Case Rep. 2018 Mar 22;2(2):yty033
pubmed: 31020114
Pulm Circ. 2020 Apr 9;10(2):2045894020917885
pubmed: 32313642
J Cardiovasc Magn Reson. 2015 Apr 18;17:29
pubmed: 25928314
J Thorac Cardiovasc Surg. 1984 Jun;87(6):876-86
pubmed: 6727410
J Cardiol. 2018 Dec;72(6):466-472
pubmed: 29898864
Heart. 2001 Nov;86(5):553-8
pubmed: 11602551
Circulation. 2015 Nov 24;132(21):2037-99
pubmed: 26534956
Pediatr Cardiol. 2019 Apr;40(4):719-725
pubmed: 30673799
Eur Respir J. 2015 Oct;46(4):903-75
pubmed: 26318161

Auteurs

Anna Kanai (A)

Department of Cardiovascular Medicine, Gunma University Graduate School of Medicine, Maebashi, Japan.

Norimichi Koitabashi (N)

Department of Cardiovascular Medicine, Gunma University Graduate School of Medicine, Maebashi, Japan.

Satoshi Akagi (S)

Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.

Hidemi Sorimachi (H)

Department of Cardiovascular Medicine, Gunma University Graduate School of Medicine, Maebashi, Japan.

Yohei Ishibashi (Y)

Department of Cardiovascular Medicine, Gunma University Graduate School of Medicine, Maebashi, Japan.

Takashi Nagasaka (T)

Department of Cardiovascular Medicine, Gunma University Graduate School of Medicine, Maebashi, Japan.

Noriaki Takama (N)

Department of Cardiovascular Medicine, Gunma University Graduate School of Medicine, Maebashi, Japan.

Katsura Soma (K)

Department of Cardiovascular Medicine, The University of Tokyo Hospital, Tokyo, Japan.

Atsushi Yao (A)

Department of Cardiovascular Medicine, The University of Tokyo Hospital, Tokyo, Japan.
Division for Health Service Promotion, The University of Tokyo, Tokyo, Japan.

Shingo Kasahara (S)

Department of Cardiovascular Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.

Masahiko Kurabayashi (M)

Department of Cardiovascular Medicine, Gunma University Graduate School of Medicine, Maebashi, Japan.

Classifications MeSH